Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Understanding alopecia is crucial to improving care and addressing hair loss concerns.

Hirsutism, excessive hair growth in women, is often caused by polycystic ovarian syndrome and is treated by targeting the cause, lifestyle changes, and medication.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

Hair loss may indicate a higher risk of heart disease and other health issues related to metabolism.

Female hyperandrogenism is a condition caused by too much male hormones, leading to skin issues and ovulation problems, often due to Polycystic Ovary Syndrome, and is treated based on individual symptoms.

Neurosteroids help control dopamine responses in the brain.

Androgens reduce macrophage receptor expression, affecting immune response, while antiandrogens counteract this effect.

Androgenetic alopecia is more common in men, often linked to genetics and hormones.

Flutamide effectively treats female pattern hair loss long-term with low doses being safe for the liver.

Some treatments like minoxidil, finasteride, and surgery can help with hereditary hair loss.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Metformin helps treat PCOS by improving fertility, reducing symptoms, and regulating periods.

Elevated testosterone, DHEA-S, and FAI help identify PCOS risk in menstrual irregularities.

PCOS in women from Karnataka is influenced by genetics, family history, and insulin resistance, requiring better diagnosis and treatment.

Testosterone replacement therapy helps manage deficiency and has various methods, but requires careful monitoring to avoid side effects.

Women with PCOS often have sleep problems, including sleep apnea, which are linked to obesity and depression.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

The diagnosis of polycystic ovary syndrome (PCOS) requires a detailed patient history, ultrasound scanning, hormone level checks, and assessments of ovulation, obesity, and insulin resistance. It's a variable condition that needs individualized management and is a significant risk factor for type 2 diabetes.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Hair loss in women with PCOS is linked to high androgen levels but the relationship is unclear.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Androgenetic alopecia is more common in men, linked to genetics and androgen levels, but routine pelvic ultrasound isn't recommended.